Clues to cell death in ALS

Neuronal cells clogged with a mutant protein associated with amyotrophic lateral sclerosis (ALS) die within hours after clumps first form, researchers report.1 The finding directly links aggregation of malformed proteins with cell death characteristic of the disease, the authors claim.By watching individual cells over the course of 48 hours, Richard Morimoto at Northwestern University and colleagues demonstrated that most cultured neurons die between 6 and 24 hours after mutant superoxide dismut

Written bySusan Brown
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Neuronal cells clogged with a mutant protein associated with amyotrophic lateral sclerosis (ALS) die within hours after clumps first form, researchers report.1 The finding directly links aggregation of malformed proteins with cell death characteristic of the disease, the authors claim.

By watching individual cells over the course of 48 hours, Richard Morimoto at Northwestern University and colleagues demonstrated that most cultured neurons die between 6 and 24 hours after mutant superoxide dismutase (SOD1) forms aggregates. Cells in which mutant SOD1 remains dispersed survive.

Morimoto suggests that the machinery for discarding misfolded proteins may have failed in some cells. Different cells may have different levels of chaperone molecules that escort unwanted molecules to the proteasome to be destroyed, he notes, and that may explain why mutated SOD1 aggregates in some cells but not others.

Steven Finkbeiner of the University of California in San Francisco – whose group demonstrated that aggregates can ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies